Literature DB >> 299880

Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes.

B Bonavida.   

Abstract

A secondary specific cytotoxic response is obtained when lymphocytes primed in vivo to a tumor allograft are exposed to Con A in culture. The secondary cytotoxic cells generated are specific to target cells bearing antigens of the primary sensitizing cells and are qualitatively indistinguishable from the response obtained upon secondary antigenic stimulation. The cell-mediated cytotoxicity is independent of concanavalin A (Con A) and is not affected by the Con A-specific inhibitor, alpha-methyl-D-mannose pyranoside. Furthermore, cultures containing a mixture of submitogenic concentrations of Con A and stimulating antigens showed synergy and augmentation of cytotoxic activity. It is suggested that activation of prekiller cells by Con A into CTL may be mediated via the same or similar receptors normally triggered by the stimulating antigens. Functional similarities between ConA and the lymphocyte-defined antigens of the major histocompatibility complex region are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 299880      PMCID: PMC2180605          DOI: 10.1084/jem.145.2.293

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  An antigen-specific component of lectin-mediated cytotoxicity.

Authors:  W R Clark
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

2.  Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens.

Authors:  B Bonavida
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

3.  Mitogen-induced lymphocyte-mediated cytotoxicity in vitro: effect of mitogens selectively activating T or B cells.

Authors:  G Möller; O Sjöberg; J Andersson
Journal:  Eur J Immunol       Date:  1972-12       Impact factor: 5.532

4.  Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.

Authors:  J D Waterfield; E M Waterfield; G Möller
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

5.  Cytotoxic effects of antigen- and mitogen-induced T cells on various targets.

Authors:  M J Bevan; M Cohn
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

6.  Secondary cell-mediated lympholysis: importance of H-2 LD and SD factors.

Authors:  B J Alter; C Grillot-Courvalin; M L Bach; K S Zier; P M Sondel; F H Bach
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

7.  Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

8.  Generation of cytotoxic T lymphocytes in vitro. II. Effect of repeated exposure to alloantigens on the cytotoxic activity of long-term mixed leukocyte cultures.

Authors:  H R Macdonald; H D Engers; J C Cerottini; K T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

9.  Synergy during in vitro cytotoxic allograft responses. I. Evidence for cell interaction between thymocytes and peripheral T cells.

Authors:  H Wagner
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.

Authors:  J C Cerottini; H D Engers; H R Macdonald; T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  9 in total

1.  Biological effects of allogeneic effect factor on T lymphocytes: in vitro induction of cytotoxic T lymphocytes manifesting preferential lytic activity against H-2-identical tumor cells.

Authors:  A Altman; T E Bechtold; J M Cardenas; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Induction of cell-mediated cytotoxicity by lipoprotein containing histocompatibility antigens.

Authors:  G Dennert
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

3.  A comparison between LCM virus-specific secondary cytotoxic T lymphocytes generated by Con A and by the homologous antigen.

Authors:  O Marker; G T Andersen
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

4.  Enhanced adoptive transfer of immunity to Listeria monocytogenes after in vitro culture of murine spleen cells with concanavalin A.

Authors:  R A Barry; D J Hinrichs
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

5.  Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.

Authors:  M Suthanthiran; P S Williams; S D Solomon; A L Rubin; K H Stenzel
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

6.  Lectin-driven maturation of cytotoxic effector cells: the nature of effector memory.

Authors:  A K Chakravarty; W R Clark
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

7.  T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity.

Authors:  H Wagner; M Röllinghoff
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

8.  On the T cell hyperreactivity of NZB mice against H-2-identical cells. Evidence for primary response characteristics and an increased helper potential.

Authors:  B Stockinger; U Botzenhardt
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

9.  Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase.

Authors:  A Novogrodsky; M Suthanthiran; B Saltz; D Newman; A L Rubin; K H Stenzel
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.